Accutar Biotechnology Announces Fast Track Designation Granted by FDA to AC0176 for the Treatment of…
Accutar Biotechnology, Inc., a clinical stage biotechnology company focusing on artificial intelligence (AI)-enabled drug discovery, announced that…